These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 25052001)
1. Clinical implications of interferon-γ genetic and epigenetic variants. Smith NL; Denning DW Immunology; 2014 Dec; 143(4):499-511. PubMed ID: 25052001 [TBL] [Abstract][Full Text] [Related]
2. Human T-bet Governs Innate and Innate-like Adaptive IFN-γ Immunity against Mycobacteria. Yang R; Mele F; Worley L; Langlais D; Rosain J; Benhsaien I; Elarabi H; Croft CA; Doisne JM; Zhang P; Weisshaar M; Jarrossay D; Latorre D; Shen Y; Han J; Ogishi M; Gruber C; Markle J; Al Ali F; Rahman M; Khan T; Seeleuthner Y; Kerner G; Husquin LT; Maclsaac JL; Jeljeli M; Errami A; Ailal F; Kobor MS; Oleaga-Quintas C; Roynard M; Bourgey M; El Baghdadi J; Boisson-Dupuis S; Puel A; Batteux F; Rozenberg F; Marr N; Pan-Hammarström Q; Bogunovic D; Quintana-Murci L; Carroll T; Ma CS; Abel L; Bousfiha A; Di Santo JP; Glimcher LH; Gros P; Tangye SG; Sallusto F; Bustamante J; Casanova JL Cell; 2020 Dec; 183(7):1826-1847.e31. PubMed ID: 33296702 [TBL] [Abstract][Full Text] [Related]
3. Association of IFN-γ +874 A/T SNP and hypermethylation of the -53 CpG site with tuberculosis susceptibility. Álvarez GI; Hernández Del Pino RE; Barbero AM; Estermann MA; Celano J; Musella RM; Palmero DJ; García VE; Pasquinelli V Front Cell Infect Microbiol; 2023; 13():1080100. PubMed ID: 36743307 [TBL] [Abstract][Full Text] [Related]
4. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414 [TBL] [Abstract][Full Text] [Related]
5. Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling. Haverkamp MH; van Dissel JT; Holland SM Microbes Infect; 2006 Apr; 8(4):1157-66. PubMed ID: 16520075 [TBL] [Abstract][Full Text] [Related]
6. A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections. Wu UI; Holland SM Semin Immunopathol; 2016 Mar; 38(2):199-212. PubMed ID: 26733044 [TBL] [Abstract][Full Text] [Related]
7. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Dupuis S; Döffinger R; Picard C; Fieschi C; Altare F; Jouanguy E; Abel L; Casanova JL Immunol Rev; 2000 Dec; 178():129-37. PubMed ID: 11213797 [TBL] [Abstract][Full Text] [Related]
8. IFN-gamma therapy of tuberculosis and related infections. Reljic R J Interferon Cytokine Res; 2007 May; 27(5):353-64. PubMed ID: 17523867 [TBL] [Abstract][Full Text] [Related]
9. Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases. Qu HQ; Fisher-Hoch SP; McCormick JB Int J Infect Dis; 2011 May; 15(5):e305-13. PubMed ID: 21330176 [TBL] [Abstract][Full Text] [Related]
10. Ethnicity based comprehensive evaluation of polymorphism in interferon-gamma gene and its association with pulmonary and extra-pulmonary tuberculosis risk: An updated trial sequential meta-analysis. Priyanka ; Sharma M; Sharma S Int J Mycobacteriol; 2021; 10(3):243-254. PubMed ID: 34494562 [TBL] [Abstract][Full Text] [Related]
11. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(5):457-68. PubMed ID: 17147054 [TBL] [Abstract][Full Text] [Related]
12. Evolutionary genetics evidence of an essential, nonredundant role of the IFN-γ pathway in protective immunity. Manry J; Laval G; Patin E; Fornarino S; Tichit M; Bouchier C; Barreiro LB; Quintana-Murci L Hum Mutat; 2011 Jun; 32(6):633-42. PubMed ID: 21448974 [TBL] [Abstract][Full Text] [Related]
13. Control of human host immunity to mycobacteria. Ottenhoff TH; Verreck FA; Hoeve MA; van de Vosse E Tuberculosis (Edinb); 2005; 85(1-2):53-64. PubMed ID: 15687028 [TBL] [Abstract][Full Text] [Related]
14. Current and future clinical applications of interferon-gamma in host antimicrobial defense. Murray HW Intensive Care Med; 1996 Oct; 22 Suppl 4():S456-61. PubMed ID: 8923089 [TBL] [Abstract][Full Text] [Related]